These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 14513945)

  • 1. Blood pressure lowering and renin-angiotensin system blockade.
    Unger T
    J Hypertens Suppl; 2003 Jul; 21(6):S3-7. PubMed ID: 14513945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor blockade and end-organ protection.
    Chung O; Unger T
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):150S-156S. PubMed ID: 10619595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the brain renin-angiotensin system in hypertension: implications for new treatment.
    Marc Y; Llorens-Cortes C
    Prog Neurobiol; 2011 Oct; 95(2):89-103. PubMed ID: 21763394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.
    Saavedra JM
    Cell Mol Neurobiol; 2005 Jun; 25(3-4):485-512. PubMed ID: 16075377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
    Haddad G; Amiri F; Garcia R
    Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does blockade of angiotensin II receptors offer clinical benefits over inhibition of angiotensin-converting enzyme?
    de Gasparo M; Levens N
    Pharmacol Toxicol; 1998 Jun; 82(6):257-71. PubMed ID: 9677617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
    Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
    Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting renin-angiotensin in the brain: the possible therapeutic implications.
    Unger T
    Blood Press Suppl; 2001; 1():12-6. PubMed ID: 11333008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are angiotensin receptor blockers neuroprotective?
    Thöne-Reineke C; Zimmermann M; Neumann C; Krikov M; Li J; Gerova N; Unger T
    Curr Hypertens Rep; 2004 Aug; 6(4):257-66. PubMed ID: 15257859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CNS renin-angiotensin system.
    von Bohlen und Halbach O; Albrecht D
    Cell Tissue Res; 2006 Nov; 326(2):599-616. PubMed ID: 16555051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
    Unger T; Culman J; Gohlke P
    J Hypertens Suppl; 1998 Sep; 16(7):S3-9. PubMed ID: 9855025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptors and functional correlates.
    Timmermans PB; Benfield P; Chiu AT; Herblin WF; Wong PC; Smith RD
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):221S-235S. PubMed ID: 1290617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system.
    Iyer SN; Yamada K; Diz DI; Ferrario CM; Chappell MC
    J Cardiovasc Pharmacol; 2000 Jul; 36(1):109-17. PubMed ID: 10892668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.